PHLDA2

gene product
BWR1C, HLDA2, IPL, TSSC3
This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver. [provided by RefSeq, Oct 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
285 antibodies from 29 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
3 antibodies
antibodies-online
107 antibodies
Bioworld Technology, Inc
1 antibody
Biorbyt
13 antibodies
Affinity Biosciences
1 antibody
LifeSpan BioSciences, Inc.
47 antibodies
Abnova Corporation
2 antibodies
Aviva Systems Biology
5 antibodies
Abgent
3 antibodies
Invitrogen Antibodies
3 antibodies
OriGene
3 antibodies
GeneTex
3 antibodies
St John's Laboratory
4 antibodies
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
1 antibody
Acris Antibodies GmbH
3 antibodies
Everest Biotech
1 antibody
NSJ Bioreagents
1 antibody
Proteintech Group
1 antibody
ProSci
2 antibodies
Arigo
1 antibody
United States Biological
50 antibodies
Creative Biolabs
7 antibodies
MyBioSource
3 antibodies
Creative Diagnostics
2 antibodies
Sigma-Aldrich
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
RayBiotech, Inc.
1 antibody